| Name | AVE5688 |
|---|
| Description | AVE5688 is an inhibitor of glycogen phosphorylase (GP), with IC50s of 430 nM and 915 nM and Kds of 170 nM and 530 nM for rabbit muscle glycogen phosphorylase (rmGPb and rmGPa, respectively); AVE5688 can be used for the research of type 2 diabetes. |
|---|---|
| Related Catalog | |
| Target |
IC50: 430 nM (rmGPb), 915 nM (rmGPa)[1] Kd: 170 nM (rmGPb), 530 nM (rmGPa)[1] |
| In Vitro | AVE5688 is an inhibitor of glycogen phosphorylase (GP), with IC50s of 430 nM and 915 nM and Kds of 170 nM and 530 nM for rabbit muscle glycogen phosphorylase (rmGPb and rmGPa, respectively)[1]. |
| Kinase Assay | Glycogen phosphorylase activity is measured in the physiological direction of glycogen breakdown. rmGP is used for the kinetic characterization of the inhibitors (AVE5688). To routinely check the phosphorylation grade of enzyme batches, activity is measured in the direction of glycogen synthesis; the phosphorylation grade is estimated from the ratio of the activity in the presence of 0.5 mM caffeine to the activity in the presence of 2 mM AMP[1]. |
| References |
| Molecular Formula | C16H8ClF5N2O5 |
|---|---|
| Molecular Weight | 438.69 |
| Storage condition | 2-8℃ |